Patient exclusion criteria
irresponsiveness, infections, hepatitis infection
PLASMA CELL LEUKEMIA, INFECTIONS
Key exclusion criteria included the following: previously documented irresponsiveness to dexamethasone monotherapy, a diagnosis of plasma cell leukemia, detectable signs of hepatitis infection, other infections requiring systemic treatment, and treatment with oral or injectable (including intra-articular) corticosteroids (CS) within 4 weeks prior to the screening visit.